Lipae, Martina .
HRN: 27-29-14 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/08/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/08/2025
06/15/2025
IVTT
90mg
Q8hours
Infectious Diarrhea
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes